Patients with heterozygous missense mutations in TREM2 demonstrate increased susceptibility to chronic neurodegenerative disorders including frontotemporal dementia (FTD)-like syndrome [23], Parkinson’s disease (PD) [24], and AD [20,25,26,27]. The gene discussed is TREM2; the disease is Parkinson disease.